1.87 USD
-0.19 (-9.22%)
1.86 USD
-0.01 (-0.53%)
ChartMill assigns a Buy % Consensus number of 78% to BTAI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.83. This target is 1067.27% above the current price.
BTAI was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about BTAI.
In the previous month the buy percentage consensus was at a similar level.
BTAI was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-12 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-08-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-15 | LUCID CAPITAL MARKETS | Reiterate | Buy -> Buy |
| 2025-06-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-19 | Rodman & Renshaw | Initiate | Buy |
| 2025-01-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-07 | B of A Securities | Downgrade | Buy -> Underperform |
| 2025-01-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-09 | UBS | Maintains | Neutral -> Neutral |
| 2024-08-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-27 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-13 | B of A Securities | Maintains | Buy -> Buy |
| 2024-02-21 | UBS | Downgrade | Buy -> Neutral |
| 2023-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-05 | Truist Securities | Downgrade | Buy -> Hold |
| 2023-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
BIOXCEL THERAPEUTICS INC / BTAI FAQ
What do analysts expect the price target to be for BIOXCEL THERAPEUTICS INC (BTAI)?
11 analysts have analysed BTAI and the average price target is 21.83 USD. This implies a price increase of 1067.27% is expected in the next year compared to the current price of 1.87.
What is the consensus rating for BIOXCEL THERAPEUTICS INC (BTAI) stock?
The consensus rating for BIOXCEL THERAPEUTICS INC (BTAI) is 78.1818 / 100 . This indicates that analysts generally have a positive outlook on the stock.